I'm hearing that in may not require that additional testing and to stay tuned.
Regarding the us distributor I actually agree with you that we need a distributor but I don't think the stock will with that news.
Only FDA and then announcing the distributor the same day or after will drive the price up.
In any event disappointing trading day for mlss looking forward to the day we get rewarded.
Who is this zack in the other page that posts daily, can't tell whether he's short, long or needs medication lol
Regarding the us distributor I actually agree with you that we need a distributor but I don't think the stock will with that news.
Only FDA and then announcing the distributor the same day or after will drive the price up.
In any event disappointing trading day for mlss looking forward to the day we get rewarded.
Who is this zack in the other page that posts daily, can't tell whether he's short, long or needs medication lol
Recent MLSS News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 07:41:03 PM
- Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025 • GlobeNewswire Inc. • 03/31/2026 08:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:02:29 PM
- Milestone Scientific Schedules Fourth Quarter and FY 2025 Financial Results and Business Update Conference Call • GlobeNewswire Inc. • 03/26/2026 01:00:00 PM
- Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion • GlobeNewswire Inc. • 02/23/2026 01:30:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/04/2026 02:26:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 10:27:54 PM
- Milestone Scientific Launches The Wand® Ambassador Program to Expand Peer Engagement and Accelerate Market Adoption in Dentistry • GlobeNewswire Inc. • 01/06/2026 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2025 09:46:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:34:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 09:01:23 PM
- Milestone Scientific Delivers Stable Revenue and Reduces Operating Expenses by Over $500 Thousand in the Third Quarter of 2025 • GlobeNewswire Inc. • 11/13/2025 09:00:00 PM
- Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call • GlobeNewswire Inc. • 11/13/2025 07:15:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/12/2025 09:07:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/29/2025 08:29:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2025 08:39:17 PM
- Milestone Scientific Highlights Operational Progress and Growth Initiatives Under New Leadership • GlobeNewswire Inc. • 10/14/2025 11:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 11:45:30 AM
- Milestone Scientific Commits to Regaining NYSE American Compliance Following Notification • GlobeNewswire Inc. • 10/14/2025 11:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/09/2025 08:55:42 PM
- Milestone Scientific Appoints Dr. Dawood Sayed to Board of Directors to Advance Commercial and Clinical Strategy in Pain Management • GlobeNewswire Inc. • 09/22/2025 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2025 08:25:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/09/2025 08:33:00 PM
- Milestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025 • GlobeNewswire Inc. • 08/14/2025 08:15:00 PM
- Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call • GlobeNewswire Inc. • 08/13/2025 03:45:00 PM
